CWB

1-methyl-N-[(1R,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]indazole-3-carboxamide

Find entries where: CWB

is present as a standalone ligand in 2 entries

Find related ligands:

Chemical Component Summary
Name	1-methyl-N-[(1R,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]indazole-3-carboxamide
Synonyms	GRANISETRON
Identifiers	1-methyl-N-[(1R,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]indazole-3-carboxamide
Formula	C₁₈ H₂₄ N₄ O
Molecular Weight	312.409
Type	NON-POLYMER
Isomeric SMILES	Cn1c2ccccc2c(n1)C(=O)NC3C[C@H]4CCC[C@@H](C3)N4C
InChI	InChI=1S/C18H24N4O/c1-21-13-6-5-7-14(21)11-12(10-13)19-18(23)17-15-8-3-4-9-16(15)22(2)20-17/h3-4,8-9,12-14H,5-7,10-11H2,1-2H3,(H,19,23)/t12-,13+,14-
InChIKey	MFWNKCLOYSRHCJ-BTTYYORXSA-N

Chemical Details
Formal Charge	0
Atom Count	47
Chiral Atom Count	2
Bond Count	50
Aromatic Bond Count	10

Drug Info: DrugBank

DrugBank ID	DB00889
Name	Granisetron
Groups	approved investigational
Description	A serotonin receptor (5HT-3 selective) antagonist that has been used as an antiemetic and antinauseant for cancer chemotherapy patients.
Synonyms	Granisetrón Granisetronum Granisetron hydrochloride Granisetron Granisétron
Brand Names	Kytril Kytril Tablets 1mg Jamp Granisetron Kytril 1mg/1ml Granisetron Hydrochloride Apo-granisetron Sustol Granisetron hydrochloride Granisol Nat-granisetron Sancuso Granisetron Hydrochloride Injection Granisetron Hydrochloride Injection Sdz Granisetron
Indication	For the prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy (including high dose cisplatin), postoperation, and radiation (including total body irradiation and daily fractionated abdominal radiation).
Categories	Alimentary Tract and Metabolism Antidepressive Agents Antiemetic Serotonin 5-HT3 Receptor Antagonists Antiemetics Antiemetics and Antinauseants Autonomic Agents Aza Compounds Azabicyclo Compounds Central Nervous System Agents Central Nervous System Depressants Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 Substrates Gastrointestinal Agents Heterocyclic Compounds, Fused-Ring Indazoles Moderate Risk QTc-Prolonging Agents Neurotransmitter Agents Peripheral Nervous System Agents Pyrazoles QTc Prolonging Agents Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome Serotonin 3 Receptor Antagonists Serotonin 5-HT3 Receptor Antagonists Serotonin Agents Serotonin Receptor Antagonists
ATC-Code	A04AA02
CAS number	109889-09-0

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
5-hydroxytryptamine receptor 3A	MLLWVQQALLALLLPTLLAQGEARRSRNTTRPALLRLSDYLLTNYRKGVR...	unknown	antagonist
Cytochrome P450 3A4	MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNI...	unknown	substrate
Cytochrome P450 1A1	MLFPISMSATEFLLASVIFCLVFWVIRASRPQVPKGLKNPPGPWGWPLIG...	unknown	substrate

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682